LANSING, Mich. (Michigan News Source) — Corewell Health is backtracking on its short-lived ban on gender-affirming hormone therapy for minors, reinstating access after legal warnings and public pressure.

The health system, which operates hospitals across Michigan, announced the policy shift on February 10th, saying that treatment decisions should be made between doctors, patients, and families.

MORE NEWS: Michigan Senate Passes Late Night Tipped Wages Bill

The reversal comes days after Corewell Health became the first Michigan hospital system to halt new hormone therapies for transgender minors, citing concerns over compliance with a federal order from President Donald Trump, according to the Detroit Free Press. 

The directive, which threatens to cut funding for hospitals providing these treatments to patients under 19, is currently being challenged in court.

Corewell Health operates in two divisions. Corewell Health East, which includes hospitals in Royal Oak and Troy, does not typically provide hormone therapy for minors. Corewell Health West, including Helen DeVos Children’s Hospital in Grand Rapids, has historically offered gender-affirming care.

“We are lifting our pause on new hormone therapies for pediatric patients seeking gender-affirming care,” Corewell Health said in a statement. “Care decisions are best made between physicians and their patients and families.”